Madrigal Pharmaceuticals, Inc. Liquidation Value

MDGL Other

Cash & Equivalents

$198.69M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $198.69M
Total Obligations: -$657.92M
$-459.23M
Per share: $-20.10
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $198.69M
AR: $134.48M
Total Obligations: -$657.92M
$-324.75M
Per share: $-14.22
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $198.69M
AR: $134.48M
Inventory: $74.84M
Total Obligations: -$657.92M
$-249.91M
Per share: $-10.94
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-459.23M$-20.10
Liquid Liquidation Value$-324.75M$-14.22
Operating Liquidation Value$-249.91M$-10.94

Key Components (as of 2025-12-31)

Cash & Equivalents$198.69M
Accounts Receivable$134.48M
Inventory$74.84M
Current Liabilities$310.29M
Long-term Debt$339.88M
Op. Lease Liability$7.75M
Finance LeaseN/A
Shares Outstanding22.8M

Explore all 164 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$198.69M$134.48M$74.84M$48.88M$310.29M$339.88M$7.75MN/A
2025-09-30$295.69M$113.28M$69.32M$44.94M$391.41M$339.75M$6.65MN/A
2025-06-30$186.19M$79.23M$63.50M$37.98M$196.50M$118.38M$5.57MN/A
2025-03-31$183.65M$61.43M$55.24M$42.06M$167.24M$118.00M$1.77MN/A
2024-12-31$100.02M$53.82M$34.07M$43.60M$169.28M$117.57M$2.00MN/A
2024-09-30$232.68M$30.46M$8.71M$45.97M$177.85M$117.09M$2.05MN/A
2024-06-30$494.60M$6.90M$7.07M$8.99M$125.16M$116.61M$1.46MN/A
2024-03-31$622.52MN/A$854,000$21.53M$114.34M$116.14M$1.59MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-19 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-08-05 View
2025-03-31 10-Q 2025-05-01 View
2024-12-31 10-K 2025-02-26 View
2024-09-30 10-Q 2024-10-31 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-07 View

Community Notes

Loading notes...

Questions

Loading questions...